Multiple research providers
One membership fee
On a single platform
A research product that matches your needs and budget
START YOUR FREE TRIAL
New Feature Release
Personalized Podcast Reports
Now you can listen to your reports on the go.
All reports are translated into 5+ languages and available to listen on Apple podcast or your Amazon Alexa.
Connecting analysts globally to investors
Give us a try!
Start your free trial to OnePass today!
( 6 mins) Press play to listen The US business community has mobilized in recent weeks to press the Biden administration for a less confrontational approach to China, including easing of tariffs and export controls. The broad principles
( 7 mins) Ethiopia’s upcoming debt restructuring negotiations will be closely watched by other sovereigns in the region and private creditors alike. While private sector involvement seems very likely, this could take the form of debt reprofiling rather
( 4 mins) President Jair Bolsonaro will talk the talk on ideological platforms but reelection in 2022 calls for pragmatism. There is increasingly little room for far-right policymaking. Stress with the arrest of a Bolsonarista congressman shows the
( 5 mins) Finance Minister Tito Mboweni’s 24 February budget benefits from better-than-expected revenue shortfalls but aims to hold the line on fiscal consolidation over the medium term. Above all, his plan to stabilize South Africa’s public finances
( 3 mins) President Alberto Fernandez continues to fight a rearguard action to limit the political fallout from last week’s revelations about a group of officials, government allies, and the well-connected who secretly received Covid-19 vaccines in violation
( 3 mins) The country’s stellar vaccination performance has had two implications on the policy front. First, the provision of a first vaccine shot to the 15mn most vulnerable people has raised the expectations for an easing of
( 4 mins) Russia is relying on vaccine diplomacy to bolster its reputation abroad amid deteriorating relations with the West and looming threat of sanctions. Low public trust in domestic vaccines from Covid-19, their production bottlenecks and Moscow’s